Streetbeat News

SNES

SenesTech, Inc.

https://www.senestech.com

Industry

Chemicals - Specialty

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Open

2.43

Mkt cap

2.3M

Volume

231K

High

2.43

P/E Ratio

0.02

52-wk high

9.80

Low

2.12

Div yield

N/A

52-wk low

1.90

SenesTech, Inc. (SNES) held its Q4 2024 earnings call, discussing financial results and company performance.

Portfolio Pulse from

March 13, 2025 | 12:45 am

SenesTech, Inc. reported a 70% increase in Q4 2024 revenue, reaching $501,000, with a gross profit margin of 61%. The company plans to reduce expenses by $2 million to accelerate profitability.

Portfolio Pulse from

March 12, 2025 | 8:30 pm

SenesTech, Inc. has announced the exercise of warrants for $1.1 million in gross proceeds, reducing the exercise price from $4.35 to $2.90 per share. The company will also issue new short-term warrants.

Portfolio Pulse from

March 10, 2025 | 12:15 pm

SenesTech, Inc. (NASDAQ: SNES) will release its Q4 and fiscal year 2024 financial results on March 12, 2025, after market close, followed by a conference call at 5:00 pm ET.

Portfolio Pulse from

March 06, 2025 | 9:30 pm

SenesTech, Inc. (Nasdaq: SNES) is expanding its market presence by introducing its fertility control solutions, Evolve™ Rat and Evolve™ Mouse, in New Zealand and Australia. This expansion is in partnership with Evicom and aligns with New Zealand's Predator Free 2050 initiative.

Portfolio Pulse from

February 25, 2025 | 2:45 pm

SenesTech, Inc. has announced a significant shipment of its Evolve Rodent Birth Control product to a major warehousing and distribution company in the Midwest, marking its expansion into this sector.

Portfolio Pulse from

February 18, 2025 | 2:00 pm

SenesTech, Inc. (Nasdaq: SNES) is expanding its global presence by entering the Indian rodent pest control market through a partnership with SMark. This move is part of their strategy to promote humane pest control solutions globally.

Portfolio Pulse from

February 04, 2025 | 4:45 pm

Baltimore has adopted SenesTech's Evolve™ rodent birth control as part of its pest management strategy to control rodent overpopulation. This move is seen as a humane and effective solution to Baltimore's rodent issues.

Portfolio Pulse from

January 21, 2025 | 1:15 pm

SenesTech, Inc. has announced the appointment of Joshua M. Moss to its Board of Directors. This move is part of the company's ongoing efforts to strengthen its leadership team.

Portfolio Pulse from

January 10, 2025 | 9:30 pm

SenesTech, Inc. reported its third quarter 2024 financial results, highlighting a 51% increase in revenue to $1.4 million for the first nine months of 2024 compared to the same period in 2023.

Portfolio Pulse from

November 12, 2024 | 9:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.